Recruiting OBSERVATIONAL NCT06051045

Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients (SEE-D)

Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients With Chronic Hepatitis D

Sponsor: Karolinska University Hospital

Conditions Chronic Hepatitis D

Interventions Bulevirtide

Updated 3 times since 2023 Last updated: Sep 27, 2023 Started: Sep 27, 2023 Primary completion: Mar 31, 2033 Completion: Mar 31, 2033

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chronic Hepatitis D and is currently actively recruiting participants. Karolinska University Hospital leads this study, which shows 3 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Oct 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska University Hospital

Data source: Karolinska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden